Recruiting

Observational Study

Sponsor:

T1D Exchange, United States

Code:

NCT04629586

Conditions

Diabetes Mellitus, Type 1

Diabetes

Type 1 Diabetes

Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

No intervention

Study Details

Brief summary:

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.

To participate, you will be asked to:

  • Read and sign an online informed consent form
  • Take a survey describing specific demographic and type 1 diabetes management information
  • Update your information annually
  • Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data

Conditions

Diabetes Mellitus, Type 1

Diabetes

Type 1 Diabetes

Diabetes Mellitus

Study ID

NCT04629586

Start date

Dec 13, 2018

Status verified date

May, 2023

Completion date

Dec 31, 2030

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Clinical diagnosis of type 1 diabetes.
  • Individuals younger than 18 years of age must have parent/guardian consent.
  • Must be able to read and understand English.
  • Currently living in the United States

Exclusion criteria:

  • Does not use insulin and has not had a pancreatic or islet cell transplant.
  • Cannot fully read and understand English.
  • Does not currently live in the United States.

Study Design

Enrollment

50000 participants

Anticipated

Interventions and Outcome Measures

Arms

Individuals diagnosed with type 1 diabetes

T1D Exchange Registry is currently looking for participants:

  • Of all ages, genders, races, and ethnic groups
  • Living in the United States
  • Diagnosed with type 1 diabetes
  • Currently taking insulin or have had a pancreatic or islet cell transplant

Interventions

No intervention

Observational research study

Primary outcome measure

  • Gather longitudinal data from individuals living with type 1 diabetes. [ Time Frame: 10 years ]

Central Contacts and Locations

Central contacts

Kelsie LaFerrier

(617) 892-9941klaferriere@t1dexchange.org

Julia Ravelson

(617) 892-9941jravelson@t1dexchange.org

Locations

T1D Exchange

Recruiting

Boston, Massachusetts, United States, 02111

Contacts

Kelsie LaFerriere

617-892-9941klaferriere@t1dexchange.org

More Information

Sponsor

T1D Exchange, United States

Last update posted

May 8, 2023

Last verified

May, 2023

Keywords

  • insulin
  • t1d
  • dm
  • diabetes
  • type 1
  • glucagon

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by T1D Exchange, United States on 2023-05-08.